Post-marketing of disease modifying drugs in multiple sclerosis: an exploratory analysis of gender effect in interferon beta treatment.
about
Relapse rates in patients with multiple sclerosis treated with fingolimod: Subgroup analyses of pooled data from three phase 3 trials.Subcutaneous interferon β-1a may protect against cognitive impairment in patients with relapsing-remitting multiple sclerosis: 5-year follow-up of the COGIMUS study.Diagnostic potential of plasma carboxymethyllysine and carboxyethyllysine in multiple sclerosisTreating multiple sclerosis with monoclonal antibodies: a 2013 update.Persistence on therapy and propensity matched outcome comparison of two subcutaneous interferon beta 1a dosages for multiple sclerosisGender issues in multiple sclerosis: an update.MRI outcomes with cladribine tablets for multiple sclerosis in the CLARITY study.Gender effects on treatment response to interferon-beta in multiple sclerosis.Polymorphisms of innate pattern recognition receptors, response to interferon-beta and development of neutralizing antibodies in multiple sclerosis patients.Multiple sclerosis registries in Europe – results of a systematic survey
P2860
Q31117462-40240A7C-32CE-4FC6-8636-1FCB3EA2302AQ31141962-9752A194-44C9-4B4B-8FA2-F3DDFC2D3F01Q34321561-B002C385-65B3-4D7E-832B-D907527ECA33Q34330211-A1D374A9-CC0B-4010-95A7-DF19047C225AQ34737478-E309D657-B591-4F79-A8F7-F41B06E568CEQ37813691-EB06DADE-B463-45F8-AA6A-F4DFC67D0283Q44298506-95491CA4-8258-4724-917B-69FA51C38ECDQ51114281-67E7FC17-9FAD-46C0-8F30-A0264E8858F9Q54665285-4D318101-80E3-44E9-B08C-51F7CDEDB0C2Q57700196-A77D68CF-6786-47D8-AFA9-C7B11A63C54D
P2860
Post-marketing of disease modifying drugs in multiple sclerosis: an exploratory analysis of gender effect in interferon beta treatment.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Post-marketing of disease modi ...... in interferon beta treatment.
@en
Post-marketing of disease modi ...... in interferon beta treatment.
@nl
type
label
Post-marketing of disease modi ...... in interferon beta treatment.
@en
Post-marketing of disease modi ...... in interferon beta treatment.
@nl
prefLabel
Post-marketing of disease modi ...... in interferon beta treatment.
@en
Post-marketing of disease modi ...... in interferon beta treatment.
@nl
P2093
P50
P1476
Post-marketing of disease modi ...... t in interferon beta treatment
@en
P2093
C Pozzilli
E Portaccio
F Pellegrini
G B Zimatore
Italian Multiple Sclerosis Database Network Group
P304
P356
10.1016/J.JNS.2009.06.036
P50
P577
2009-07-16T00:00:00Z